Adults aged 75 years or older should receive an RSV protein subunit vaccine; receipt can be considered for those aged 60 to 74 years at increased risk ...
Top FDA drug official is trying to hire a friend who's seeking a bold new warning on antidepressants
The Food and Drug Administration is reviewing a request for new warnings on antidepressant drugs, and that's presenting an ...
The new schedule no longer universally recommends that children be vaccinated against influenza, hepatitis A and B, RSV, rotavirus and meningitis. Kennedy framed the changes as a way to restore choice ...
Robert F. Kennedy Jr. is waging a multifront war on vaccines, and confidence in them is waning. His main victims, of course, are kids — more than 3,000 measles cases have been reported since he took ...
The lawsuit asks the court to nullify the CDC's decision to reduce the number of immunizations that are recommended for ...
Gavin Newsom announced Tuesday that he would help spearhead a multi-state lawsuit against US Health Secretary Robert F.
In healthy, nonpregnant women, the multidose vial presentation of the respiratory syncytial virus prefusion F protein vaccine (RSVpreF) matched the licensed single-dose vial in neutralizing immune ...
I’ve spent a large part of my professional life working to improve the health of our Louisiana children. As the executive director for the Louisiana Partnership for Children and Families, I helped ...
It has been a brutal viral season, but as RSV cases surged in New York, Northwell Health doctors say infant hospitalizations remained down. They credit a fairly new vaccine for that. It is ...
Respiratory tract infections continue to impose a substantial global disease burden, with lower respiratory tract infections remaining the leading cause of death worldwide. According to 2021 data from ...
Two major medical groups will begin reviewing vaccine safety and effectiveness after major changes at the U.S. Centers for Disease Control and Prevention (CDC) have raised alarms among experts. The ...
The American Medical Association (AMA) on Tuesday announced the launch of its own “evidence-based review process” of vaccine safety and efficacy for the next respiratory viral season, an apparent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results